ENTX — Entera Bio Ltd.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2018-06-28.
Performance
Technicals
Others in Healthcare
Measured signals that fired on ENTX
| date | signal | measured base rate |
|---|---|---|
| 2026-07-27 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
| 2026-05-13 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
| 2026-04-06 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
| 2026-03-12 | Short volume far above its own normal short | -0.76% over 21 days · t = -2.79 · n = 5,897 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-08-07 | Malca Yonatan Director | Grant or award | 22.8K | 0.00 | 0 |
| 2026-08-07 | Ellis Sean Director | Grant or award | 20.0K | 0.00 | 0 |
| 2026-08-07 | Germano Geno J Director | Grant or award | 25.0K | 0.00 | 0 |
| 2026-08-07 | Rubin Steven D Director | Grant or award | 19.1K | 0.00 | 0 |
| 2026-08-07 | Taitel Haya Director | Grant or award | 20.8K | 0.00 | 0 |
| 2026-07-14 | Toledano Miranda Jayne Chief Executive Officer | Grant or award | 73.0K | 0.00 | 0 |
| 2026-07-14 | Toledano Miranda Jayne Chief Executive Officer | Grant or award | 347.6K | 0.00 | 0 |
| 2026-05-07 | Galitzer Hillel Chief Operating Officer | Grant or award | 73.0K | 0.00 | 0 |
| 2026-05-07 | Yaacov-Garbeli Dana Chief Financial Officer | Grant or award | 58.4K | 0.00 | 0 |
| 2026-05-07 | Burshtein Gregory Chief of R&D | Grant or award | 87.6K | 0.00 | 0 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| Knoll Capital Management, LLC | 6.5M | 5.9M |
| RENAISSANCE TECHNOLOGIES LLC | 525.5K | 473.4K |
| Parkman Healthcare Partners LLC | 320.4K | 288.7K |
| CITADEL ADVISORS LLC | 272.6K | 245.6K |
| Seven Fleet Capital Management LP | 228.2K | 205.5K |
| MARSHALL WACE, LLP | 217.3K | 195.8K |
| NORTHERN TRUST CORP | 163.0K | 146.9K |
| XTX Topco Ltd | 146.1K | 131.6K |
| Schonfeld Strategic Advisors LLC | 61.3K | 55.2K |
| SIGNATURE ESTATE & INVESTMENT ADVISORS LLC | 52.5K | 47.3K |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 8-K | 2026-08-18 | 2026-08-18 | on EDGAR ↗ |
| D | 2026-08-12 | — | on EDGAR ↗ |
| 4 | 2026-08-07 | 2026-08-07 | on EDGAR ↗ |
| 4 | 2026-08-07 | 2026-08-07 | on EDGAR ↗ |
| 4 | 2026-08-07 | 2026-08-07 | on EDGAR ↗ |
| 4 | 2026-08-07 | 2026-08-07 | on EDGAR ↗ |
| 4 | 2026-08-07 | 2026-08-07 | on EDGAR ↗ |
| 4 | 2026-08-07 | 2026-08-07 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Entera Bio Ltd. (ENTX) filed form 8-K · 2026-08-18 · SEC EDGAR
- Entera Bio Ltd. (ENTX) filed form 8-K · 2026-08-18 · SEC EDGAR
Ask the AI about ENTX
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →